BSE filing, NSE: HEALTHX. Summary written from the filing by ALFA Finder's alert engine.
Health X Platform Ltd: key numbers
- Share price
- ₹279.70
- Market cap
- ₹889.7 Cr
- Revenue (annual)
- ₹1,319 Cr
- Net profit (annual)
- ₹1.18 Cr
- P/E (TTM)
- -44.1×Sector 51.1×
- Promoter holding
- 74.07%+0.00% QoQ
- FII holding
- 2.32%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Health X Platform Ltd
All →Health X Platform Other Announcement
Health X Platform Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Listing Regulations.
Health X Platform Annual General Meeting
Health X Platform Limited held its 37th Annual General Meeting on September 28, 2026. Members transacted ordinary and special business, including financial statements and director re-appointments.
Health X Platform Annual Report
Health X Platform Limited has filed its Annual Report for the financial year 2025-26. The company reported a consolidated total revenue of Rs. 1,319.27 Crore for the period.
Health X Platform Annual General Meeting
Health X Platform Limited will hold its 37th Annual General Meeting on September 28, 2026, via video conferencing. The meeting notice and annual report will be submitted later.
Health X Platform Earnings Call Transcript: Key Takeaways
Health X is aggressively scaling its digital B2B and B2C pharmacy platforms, showing strong top-line momentum while burning cash on technology and geographical expansion.
- Call
- Guides 100% growth
Health X Platform Investor Presentation: Key Takeaways
Health X Platform reports strong Q1 FY27 growth with revenue at ₹440.3 Cr and 7.8% gross margins, leveraging its B2C SastaSundar and B2B Retailer Shakti ecosystems.
- Call
- Guides 30% growth
Other other announcement announcements
All →Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.
Avience Biomedicals Other Announcement
Avience Biomedicals confirmed corporate governance compliance is not applicable, as it is SME-listed on NSE Emerge. No quarterly governance report is required for September 2026.